Chronic Condition Management

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

Fujirebio Diagnostics’ test, which received 510k clearance Friday, will “assist physicians and patients to obtain an AD diagnosis in early stages of the disease.”

Optimizing revenue cycle management for mental health providers, and how primary care physicians can help bridge the gap.

Expert physicians discuss the urgent need to rebuild trust in vaccines amid rising skepticism and misinformation during the Trump administration, emphasizing the role of physicians in public health.

Panel discusses need for communication and importance of primary care in relation to oncology and cancer treatments.

Ultraprocessed foods, oil-based dyes are FDA targets as part of Make America Healthy Again initiative.

Make America Healthy Again, HHS all on the agenda this week in U.S. Senate.

National Comprehensive Cancer Network holds policy summit on collaboration in oncology, primary care.

An expert physician panel discusses how vaccine policy has gone wrong under the Trump administration, why misinformation has flourished and what individual physicians can do to win back patient trust.

National Comprehensive Cancer Network holds cancer policy summit for collaboration to benefit patients.

AI-driven analytics revolutionizes primary care, enhancing chronic disease management and preventive strategies while alleviating physician burdens for better patient outcomes.

Primary care physicians are often in the best position to identify and treat patients with AUD.

Navigating prescription affordability is crucial for patient care, ensuring access to necessary medications and fostering open discussions about financial options.

‘Wild west’ of pharmaceutical sales developed as patients clamor for GLP-1s for obesity treatment.

Fear, inconvenience and distrust in doctors are keeping patients away from preventive care — even as health risks climb.

Teen drinking poses serious risks to adolescent health, affecting brain development and increasing addiction potential. There are effective strategies to address this issue.

Dementia costs will soar to $781 billion by 2025, driven by unpaid caregiving and lost income, highlighting the emotional toll on families.

The FDA announces a phased ban on oil-based food colorings, prioritizing children's health and promoting natural alternatives in American foods.

$1M grant includes scholarships for physician training in lifestyle medicine.

The company received the designation for its atrioventricular interval modulation therapy, a novel pacemaker-based treatment aimed at reducing blood pressure in patients with uncontrolled hypertension and elevated cardiovascular risk.

Device uses an adaptive algorithm to automatically adjust and correct glucose levels every five minutes around the clock.

A new framework uses machine learning and social determinants of health to optimize clinician encounters and reduce care inequities.

Businesses challenge authority to require health insurance coverage for free screenings for cancer, other ills.

A University of Michigan program using digital monitoring slashed hospitalizations by nearly 60%, offering a model for scalable post-discharge care.

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?